Avidity Biosciences (RNA) Leases (2020 - 2025)
Historic Leases for Avidity Biosciences (RNA) over the last 6 years, with Q3 2025 value amounting to $52.8 million.
- Avidity Biosciences' Leases rose 73899.03% to $52.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $52.8 million, marking a year-over-year increase of 73899.03%. This contributed to the annual value of $5.6 million for FY2024, which is 3206.38% down from last year.
- Per Avidity Biosciences' latest filing, its Leases stood at $52.8 million for Q3 2025, which was up 73899.03% from $4.2 million recorded in Q2 2025.
- Over the past 5 years, Avidity Biosciences' Leases peaked at $52.8 million during Q3 2025, and registered a low of $45000.0 during Q3 2021.
- Moreover, its 5-year median value for Leases was $7.8 million (2023), whereas its average is $9.0 million.
- In the last 5 years, Avidity Biosciences' Leases crashed by 8793.57% in 2021 and then skyrocketed by 2048666.67% in 2022.
- Over the past 5 years, Avidity Biosciences' Leases (Quarter) stood at $10.8 million in 2021, then decreased by 18.81% to $8.8 million in 2022, then dropped by 5.53% to $8.3 million in 2023, then plummeted by 32.06% to $5.6 million in 2024, then skyrocketed by 840.52% to $52.8 million in 2025.
- Its last three reported values are $52.8 million in Q3 2025, $4.2 million for Q2 2025, and $4.9 million during Q1 2025.